Affiliation:
1. The Second Affiliated Hospital of Chongqing Medical University
2. Army Medical University, Third Military Medical University
Abstract
Abstract
Background
Cryptorchidism is characterized by undescended or incomplete descent of the testes. The pathogenesis of cryptorchidism has not been fully elucidated. In addition, patients with cryptorchidism are at a higher risk of malignancy than normal individuals, and its etiology and underlying molecular mechanisms need to be further investigated.
Methods
Datasets GSE16191 and GSE25518 were downloaded from the Gene Expression Omnibus database to identify the common differentially expressed genes (DEGs). Gene enrichment analyses were performed using the WebGestalt database. A protein-protein interaction network of DEGs was constructed using the STRING database, of which hub genes were identified by Cytoscape software. The GEPIA database was used to validate the expression of the hub genes of cryptorchidism in testicular cancer, and then the protein level of genes was detected in the HPA database. The analysis of immune cell infiltration was conducted in the R package. The clinical significance of the selected genes was analyzed from four aspects: clinical correlation, overall survival (OS), recurrence-free survival (RFS), and receiver operating characteristic (ROC) curve.
Results
Of the 438 common DEGs identified, 134 were up-regulated and 304 were down-regulated. Biological functions analysis identified important signaling pathways, key functional modules, and co-expression networks in cryptorchidism. Nine hub genes (HNRNPM, SF1, U2SURP, SNRPA1, AQR, RBM39, PCBP2, RBM5, and HNRNPU) were identified in cryptorchidism, four (SF1, HNRNPM, RBM5, and AQR) of which were significantly expressed in testicular cancer. The high expression of the genes SF1 and HNRNPM predicted poor RFS in cancer patients. Moreover, genes AQR and HNRNPM may contribute to malignant transformation from cryptorchidism to cancer via the spliceosome pathway.
Conclusion
Our study revealed the potential molecular mechanisms under the pathogenesis of cryptorchidism and its carcinogenesis. The biomarkers identified in this study may provide a theoretical basis and new ideas for further mechanism research of cryptorchidism.
Publisher
Research Square Platform LLC
Reference34 articles.
1. Variability among Canadian pediatric surgeons and pediatric urologists in the management of cryptorchidism in boys before the publication of major guidelines: a retrospective review of a single tertiary centre;Kim JK;Can J Surg,2019
2. Evaluation and treatment of cryptorchidism: AUA guideline;Kolon TF;J Urol,2014
3. Expression Atlas update–a database of gene and transcript expression from microarray- and sequencing-based functional genomics experiments;Petryszak R;Nucleic Acids Res,2014
4. NCBI GEO: archive for functional genomics data sets–update;Barrett T;Nucleic Acids Res,2013
5. EGR4 is a master gene responsible for fertility in cryptorchidism;Hadziselimovic F;Sex Dev,2009